Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. [electronic resource]
Producer: 20200720Description: 743-e205 p. digitalISSN:- 1549-490X
- Administration, Oral
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Aromatase Inhibitors -- administration & dosage
- Breast Neoplasms -- drug therapy
- Dehydroepiandrosterone -- administration & dosage
- Disease Progression
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Humans
- Middle Aged
- Prospective Studies
- Receptors, Androgen -- metabolism
- Receptors, Estrogen -- metabolism
- Response Evaluation Criteria in Solid Tumors
- Survival Analysis
- Time Factors
- Triple Negative Breast Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.